Recently, Beijing Hybribio Medical Laboratory’s COVID-19 nucleic acid testing and other expanded items have been awarded
Winter and spring are the peak seasons for influenza A and B. At present, COVID-19 is still developing. The infections o
In mid-December, the United Kingdom reported to the World Health Organization for the first time the emergence of a new
Hybribio (Stock code: 300639.SZ) is the leading supplier of nucleic acid molecular diagnostic products in China, with a complete operation chain, from research and development, production, to sales. In 2017, Hybribio was listed in GEM of Shenzhen Stock Exchange....